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Abstract
In vitro corticogenesis fromembryonic stem cells (ESCs) is an attractivemodel of cortical development and a promising tool for cortical
therapy. It is unknown towhich extent epigeneticmechanisms crucial for cortex development and function, such as parental genomic
imprinting, are recapitulated by in vitro corticogenesis. Here, using genome-wide transcriptomic andmethylation analyses on hybrid
mouse tissues and cells, we find a high concordance of imprinting status between in vivo and ESC-derived cortices. Notably, in vitro
corticogenesis strictly reproduced the in vivo parent-of-origin-dependent expression of 41 imprinted genes (IGs), including Mest and
Cdkn1c known to control corticogenesis. Parent-of-origin-dependent DNAmethylation was also conserved at 14 of 18 imprinted
differentially methylated regions. The least concordant imprinted locus was Gpr1-Zdbf2, where the aberrant bi-allelic expression of
Zdbf2 and Adam23was concomitant with a gain of methylation on the maternal allele in vitro. Combined, our data argue for a broad
conservationof the epigeneticmechanisms at imprinted loci in cortical cells derived fromESCs.Wepropose that in vitro corticogenesis
helpstodefine thestill poorlyunderstoodmechanismsthat regulate imprinting in thebrainandthe rolesof IGs incorticaldevelopment.
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Introduction
It is likely that neocortical neurogenesis in humans (Bhardwaj
et al. 2006) and mice (Ehninger and Kempermann 2003) are re-
stricted to the developmental period. Promising sources of neu-
rons to repair the damaged adult cortex are cortical-like cells
obtained in vitro through selective differentiation of mouse
(Eiraku et al. 2008; Gaspard et al. 2009) or human (Shi et al.
2012; Espuny-Camacho et al. 2013) ESCs. To which extent in
vitro corticogenesis recapitulates the in vivo process is an impor-
tant issue that is highly debated (Lancaster andKnoblich 2014; Li-
vesey et al. 2015). In light of the biological parameters that have
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beenmeasured so far, in vitro cortical-like cells fromESCs seema
worthy source of cells for cortical therapy and a valuable model
system for corticogenesis. In vitro corticogenesis from ESCs nota-
bly reproduces the temporal expression of markers of cortical
layers and projections of axons upon grafting into a recipient
mouse cortex (Eiraku et al. 2008; Gaspard et al. 2008; Hansen
et al. 2011; Espuny-Camacho et al. 2013). In addition, ESC-derived
cortical cells grafted in the visual cortex respond to visual stimuli
(Michelsen et al. 2015), suggesting that these cells could function-
ally reconstitute a damaged cortical circuit.
A remaining concern and unanswered issue about in vitro
cortex is its epigenetic signature. During development, the gen-
eration of a comprehensive repertoire of differentiated cells par-
allels a complex reorganization of the epigenetic landscape
(Thiagarajan et al. 2014). Changes in the epigenetic signature or-
chestrate the regulation of developmental genes such as Neuro-
genin1 in the developing cortex (Hirabayashi et al. 2009).
Mutations in the epigenetic machinery lead to specific neurode-
velopmental diseases (Jakovcevski and Akbarian 2012). In vitro
culture can also alter DNA methylation patterns (Lund et al.
2012; Cahan and Daley 2013; Thiagarajan et al. 2014). Hence, a
major hurdle for the use of ESCs in cortical development studies
and cortical therapy is to prove that ESC-derived cortical cells re-
produce the epigenetic signature of the in vivo cortex.
The so-called imprinted genes (IGs) are particularly relevant
in this context as they display allele-specific expression depend-
ing on the epigenetic status of both parental genomes and many
are involved in corticogenesis. Parental genomic imprinting is an
epigenetic mechanism that restrains the expression of approxi-
mately 140 IGs in mouse and human to one parental allele (Kel-
sey and Feil 2013). This parent-of-origin-dependent expression is
due to methylationmarks deposited on differentiallymethylated
DNA regions (DMRs) during female andmale gametogenesis that
distinguish the genomes inherited from the mother and the
father (Ferguson-Smith 2011; Kelsey and Feil 2013). For example,
at the Dlk1-Dio3 imprinted locus, methylation is restrained to the
paternal DMR and neighboring IGs are exclusively expressed
either from the paternal (Dlk1 and Rtl1) or from the maternal
(Meg3 and Mirg) allele (Ferguson-Smith 2011; Kelsey and Feil
2013). Depending on tissue and developmental stage, a given IG
is expressed exclusively from one parental allele, expressed pre-
ferentially from one parental allele with an incomplete silencing
of the normally repressed allele, or expressed equally from both
parental alleles (Prickett and Oakey 2012; Bonthuis et al. 2015).
Brain is a known hotspot for tissue-specific imprinting (Prickett
and Oakey 2012), as recently confirmed by RNA-seq experiments
on F1 hybrid whole brain (Wang et al. 2008, 2011; DeVeale et al.
2012; Babak et al. 2015). For instance, Ube3a, whose loss of func-
tion results in Angelman syndrome, is bi-allelically expressed
in most organs, while it is maternally expressed in neurons
(Albrecht et al. 1997; Chamberlain and Lalande 2010). Moreover,
some IGs play a key role in cortical development: Cdkn1c and
Igf2 regulate progenitor proliferation (Lehtinen et al. 2011;
Mairet-Coello et al. 2012; Tury et al. 2012) and Dlk1 regulates neu-
rogenesis in the postnatal niche (Ferron et al. 2011). Mest mutant
mice display alteration of motor cortex patterning (Sansom et al.
2005). IGs are also involved in human corticogenesis. Microce-
phaly (Mueller and Coovadia 2008) or hypoplasia of the corpus
callosum (Mackay et al. 2008) has been observed in some patients
with imprinting disorders. Imprinting can be affected by the pro-
cess of culturing cells and organs in vitro (Dean et al. 1998; Lund
et al. 2012) and themaintenance of genomic imprints is therefore
commonly used to evaluate epigenetic stability during cell cul-
ture, notably in ESCs and their derivatives (Dean et al. 1998;
Pick et al. 2009; Lund et al. 2012; Ficz et al. 2013; Greenberg and
Bourc’his 2015; Stelzer et al. 2015). Nevertheless, the parent-of-
origin-dependent gene expression and methylation of all the
murine imprinted loci in the cerebral cortex generated both in
vivo and in vitro fromESCs areunknown. A thorough comparison
of both repertoires should help to validate or invalidate the im-
printing status of ESC-derived neural cells.
Here, using RNA-seq and RRBS on F1 hybrid mouse cells and
tissues, we show that cortical cells generated from ESCs reflect
the in vivo cortex with respect to the parent-of-origin-dependent
gene expression and DNA methylation at most imprinted loci.
Thus, in vitro corticogenesis should help to identify the function
of thesewell-conserved IGs in corticogenesis aswell as the poorly
known mechanisms of brain-specific imprinting.
Material and Methods
ESC Lines and In Vitro Corticogenesis from Embryonic
Stems Cells
E14Tg2a (E14) embryonic stems cells (ESCs) were maintained on
gelatin-coated dishes in DMEM (Life Technologies) supplemented
with 15%ES-certifiedFBS (Life Technologies), 0.1 mMnonessential
amino acids (Life Technologies), 1 mM sodium pyruvate (Life
Technologies), 0.1 mM β-mercaptoethanol (Sigma), 50 U/mL peni-
cillin/streptomycin, and 10³ U/mL LIF (Millipore) as previously de-
scribed (Gaspard et al. 2009). Hybrid BJ1 (♀C57BL/6J × ♂JF1/Ms) F1
and JB6 (♀JF1/Ms × ♂C57BL/6J) F1 ESCs were described in Kota
et al. (2014). These cells weremaintained on gelatin-coated dishes
in ESGRO complete plus medium (Millipore, SF001-500P), which
contains LIF, BMP4 (Ying et al. 2003), and a GSK3β inhibitor (Ying
et al. 2008). Note that BJ1 corresponds to BJ1 line while JB6 is
named JB1 line in Kota et al. (2014).
To generate cortical cells in vitro, E14 ESCswere differentiated
as described previously (Gaspard et al. 2009). Hybrid ESCs were
differentiated as E14 ESCs, except that they were plated ontoma-
trigel (human ESC qualified matrix, BD)-coated dishes and that
DDMwas supplementedwith B27 (without vitamin A) to improve
their survival (Kota et al. 2014). For all lines, DDM medium was
supplemented with cyclopamine (1 μM) from day 2 to 10 to en-
hance dorsalization of telencephalic progenitors as described
previously (Gaspard et al. 2009). Differentiation was stopped
after 12 or 21 days of culture.
All animal procedureswere conducted in accordancewith the
protocol approved by the Institutional Animal Care and Use
Committee.
Immunofluorescence and Imaging
Immunofluorescence experiments were performed as described
in Gaspard et al. (2009). Primary antibodies were incubated over-
night at 4 °C and secondary antibodies for 2 h at room tempera-
ture. Nuclei were stained with DAPI. Coverslips were mounted
with Mowiol. Five to 10 different areas per coverslip were exam-
ined with an AxioimagerZ1 fluorescent microscope (Zeiss). The
proportions of E14, BJ1, or JB6 cells expressing NESTIN, TUBB3,
and GFAP were measured semi-automatically by measuring the
proportions of marker-positive areas into the total DAPI-labeled
areas on low magnification images, as described by Sun et al.
(2013). In more details, the 3 markers were detected with the
same Cy3 secondary antibody and total cells were labeled with
DAPI. All immunofluorescence data were acquired with the
same highly stringent parameters to remove unspecific signal,
which may result in underestimation of the % of cells positive
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for a given marker, using an imagerZ1 microscope (Zeiss). For
each coverslip, 25 images were taken at low magnification (×5)
using the Mosaic mode for DAPI and Cy3 (NESTIN, TUBB3, or
GFAP). Areas occupied by all the cells (“areaBlue”, DAPI) and by
the cells expressing the marker of interest (“areaMarkerInBlue”,
Cy3) were then determined on the reconstituted image (equiva-
lent to 25 images at ×5) using a homemade script in Fiji (available
upon request). The percentage of area occupied by the marker in
total (DAPI) area was calculated as follows: (areaMarkerInBlue/
areaBlue) * 100.0. Data are the average of 3–4 independent differ-
entiations. Antibodies are listed in Supplementary Experimental
Procedures.
RT-qPCR
RT-qPCR was done as described in Al Adhami et al. (2015). Briefly,
total RNAs were reverse-transcribed using MMLV-RT and N6 pri-
mers (Life Technologies). Quantitative PCR (qPCR) was performed
in duplicate or triplicate using SYBR Green Mix (Roche) on a Light
Cycler LC480 Real-Time PCR system (Roche) in 384well plateswith
2 ng of equivalent RNA per point of qPCR. The selection of house-
keeping genes was performed using geNorm (Vandesompele et al.
2002). The level of expressionof eachgeneXwasnormalized to the
geometric mean of the expression levels of 3 housekeeping genes
R (Gus, Tbp, and Gapdh) according to the formula: X/geometric
mean (R1, R2, R3) = 2−[Cp(X)− arithmetic mean (Cp(R1),Cp(R2),Cp(R3)], where
Cp is the crossing point. Quantitative PCR primers are listed in
Supplementary Table 1.
RNA-seq
Cells and brain tissues were lysed in RNA now and total RNAs
were prepared according to the manufacturer’s instructions
(Ozyme). RNAs were DNAse-treated (Ambion) and their integrity
was checked on a 2100 Bioanalyser (Agilent). Strand-specific RNA
sequencingwas performed at theMGX facility (www.mgx.cnrs.fr)
with 3–4 replicates per reciprocal cross of in vivo cortex at em-
bryonic day 13.5 (E13.5) and P0, 2 replicates of undifferentiated
BJ1 and JB6 ESCs, BJ1 and JB6 ESCs differentiated into cortex for
12 and 21 days, and 3 replicates of E14 at d12 and d21. Thirty to
50 million high-quality 50 nt single-end reads per sample were
generated using Illumina HiSeq 2000 (see Supplementary
Table 2). The reads that passed the base caller purity filter (see
Supplementary Table 2) were aligned to a hybrid B6/JF1 mRNAs
sequence set with IUPAC ambiguous codes at single-nucleotide
polymorphisms (SNPs) using Novoalign (Novoutil IUPAC). The
B6-JF1 SNPs were downloaded from ftp://molossinus.lab.nig.ac.
jp/pub/msmdb/For_Seq_Analysis (Takada et al. 2013). The E14
129P2 reads were aligned against a hybrid B6/129P2 genome
where all the B6 baseswere replacedwith their 129P2 counterparts
at all known B6–129P2 SNP positions. The B6–129P2 SNPswere ob-
tained from the Sanger Institute. Counting of different bases at
SNPpositionswas performedusing SAMtools/mpileup. The anno-
tation of SNPs was performed using Annovar (Wang et al. 2010).
More details regarding processing and analysis of RNA-seq
data can be found in Supplementary Experimental Procedures.
The RNA-seq data from this study have been submitted to the
NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.
gov/geo/) under accession number GSE58523.
Statistics to Determine Parent-of-Origin-Dependent
Expression from RNA-seq Data
We designed a novel statistical method to test for the parent-of-
origin-dependent gene expression. This method, called ISoLDE
for Integrative Statistics of alleLe Dependent Expression, is a
robust nonparametric adaptation of the classical z-test to
compare 2 proportions. Robustness was improved through the
use of the median absolute deviation as a quantification of
expression variability among replicates. This method is exten-
sively described in Supplementary Material (and Reynès et al.
in preparation) and available as a Bioconductor package (http://
bioconductor.org/packages/ISoLDE/).
Confirmation of Parent-of-Origin-Dependent Expression
by Restriction Fragment Length Polymorphism Analysis
and Sanger Sequencing
The measurement of parent-of-origin-dependent expression
was essentially performed as described in Kohda et al. (2006).
Briefly, genomicDNAand cDNA fromESCs (d0, d12, and d21), dor-
sal telencephalon (DTand E13.5), and cortex (P0)were PCR-ampli-
fied using Taq (NEB) with primers surrounding the polymorphic
region. Two techniques were used depending on the nature of
the polymorphism: (1) analysis by restriction fragment length
polymorphism (RFLP) as for Meg3 using Bsh1236i, H19 using
BclI, or Peg3 using TaqI; (2) direct sequencing of the PCR ampli-
cons for Dlk1, Peg10, Osbpl15, Phactr2, Nap1l4, and Dhcr7. PCR pro-
ducts were purified and sequenced by Cogenics. Primer
sequences are listed in Supplementary Table 1.
Reduced Representation Bisulfite Sequencing
Genomic DNAs were prepared using PureLink genomic DNA kit
(Life Technologies). Reduced representation bisulfite sequencing
(RRBS) was performed on 13 conditions in duplicates: E14 (at d0,
d12, and d21), BJ1 (at d0, d12, d21, E13.5, and P0), and JB6 (at d0,
d12, d21, E13.5, and P0) as described by Auclair et al. (2014) with
slight modifications. Briefly, 200 ng of genomic DNA were di-
gested with MspI (Thermo Scientific) for 5 h, followed by end-re-
pair, A-tailing (with Klenow fragment, Thermo Scientific), and
ligation to methylated indexed Illumina adapters using a T4
DNA ligase (Thermo Scientific) in Tango 1× buffer. Fragments
were purified using AMPure XP magnetic beads (Agilent) as de-
scribed in Boyle et al. (2012). Two rounds of bisulfite conversion
were then performed using the EpiTect kit (Qiagen). Final RRBS li-
braries were PCR-amplified with PfuTurbo Cx hotstart DNA poly-
merase (Agilent) as follows: 95 °C for 2 min, 14 cycles (95 °C for
30 s, 65 °C for 30 s, and 72 °C for 45 s), 72 °C for 7 min. The libraries
were purified with AMPure magnetic beads, quantified with a
Qubit fluorometer (Life Technologies), and verified by Fragment
analyzer (Advanced Analytical) and qPCR (Roche). Directional li-
braries were sequenced (100 nt single-end reads) on an Illumina
HiSeq2000 at MGX facility. Reads were processed and analyzed
with tools developed at the Brabaham Institute (Trim_galore, Bis-
mark; (Krueger and Andrews 2011) and Seqmonk). An average of
30 million reads per sample were mapped and bisulfite conver-
sion rate was 99.83 ± 0.09% for the 26 samples (see Supplemen-
tary Table 5). Hybrid samples displayed 12–13% informative
reads for each genome (C57BL/6 and JF1; not shown). More details
are provided in Supplementary Material. RRBS data have been
submitted under accession number GSE75485.
Methylation Analysis by Targeted Bisulfite Sequencing
of Specific Loci
DNA extraction was done as previously described (Arnaud et al.
2006) and bisulfite conversion was performed using the EZ DNA
methylation™ Gold Kit from Zymo (ref. D5006), according to the
manufacturer’s instruction. PCR amplifications, cloning, and
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sequencing of specific lociwere performed aspreviously described
(Arnaud et al. 2006). Primers are listed in Supplementary Table 1.
Results
Corticogenesis from Hybrid ESCs
To investigate the parent-of-origin-dependent gene expression
and DNA methylation profiles of in vivo and in vitro cortices,
we designed an experimental strategy (see Supplementary
Fig. 1) that takes advantage of the 12 508 968 strain-specific
SNPs identified between the genomes of C57BL/6J—hereafter
called B6—and M. m. molossinus JF1/Ms—hereafter called JF1—
mouse strains (Takada et al. 2013). Reciprocal crosses between
B6 and JF1 mice were done to ensure that we measured parental
genome-specific differences and not strain biases (Wang and
Clark 2014; see Supplementary Fig. 1).
We dissected out dorsal telencephalon (DT), the presumptive
cortex, at E13.5 and the cerebral cortex at birth (P0) of BJ1 (B6
mother × JF1 father) and JB6 (JF1 mother × B6 father) hybrids
(see Supplementary Fig. 1). In parallel, we took advantage of BJ1
and JB6 ESC lines that we recently characterized (Kota et al.
2014; Maupetit-Mehouas et al. 2016) to generate cortical-like
cells in vitro (see Supplementary Fig. 1). We used an established
protocol that recapitulates the sequential steps of in vivo cortico-
genesis, including the progressive generation of dorsal telence-
phalic progenitors, neurons, and finally glia (Gaspard et al.
2008, 2009). We slightly modified this protocol, initially set up
for E14Tg2a ESCs (E14 for short), which are derived from the
inbred 129P2 mouse strain, to improve the survival of BJ1 and
JB6 hybrid ESC-derived neural progenies [see “Material andMeth-
ods” and Kota et al. (2014)]. We focused our study on days 12 (d12)
and 21 (d21) of in vitro corticogenesis, because in E14 ESC-derived
cells, neural progenitors and neurons form themain cell popula-
tion at d12 and d21, respectively (Gaspard et al. 2008). Hence, the
d12 and d21 cellular compositions grossly resemble those of
E13.5 DT and P0 cortex, respectively (Gaspard et al. 2008). The
B6 mice that were used to generate BJ1 and JB6 ESC lines carried
a Pou5f1-GFP transgene that was no longer expressed at d12 and
d21 of in vitro corticogenesis, as expected for a pluripotency mar-
ker (Fig. 1A). Transcripts for markers of proliferation (Pcna) and
pluripotency (Pou5f1 and Nanog) decreased during E14 and hybrid
ESC-derived corticogenesis (Fig. 1B), in linewith theGFPexpression
pattern (Fig. 1A). In contrast, neural (Nestin, Tubb3, and Fabp7) and
cortical (Pax6, Coup-Tf1, Emx1, Bf1, and Otx2) markers increased in
hybrid- as well as in E14-derived cortical cells (Fig. 1B). Immuno-
fluorescence experiments confirmed that neural progenitors (NES-
TIN+ cells) increased from d0 to d12, and neurons (TUBB3+ cells)
(Fig. 1C–E) and glial cells (GFAP+ cells; not shown) increased from
d12 to d21 in proportions that were not significantly different be-
tween E14 and hybrid cells (Fig. 1C,D). Hybrid neural progenitors
(NESTIN+ cells) also expressed the cortical marker PAX6 (Fig. 1E).
Furthermore, the hybrid neurons expressed the known markers
of cortical layers REELIN, TBR1, CTIP2, and BRN2 at d21 (Fig. 1F).
Taken together, these data show that hybrid cells generated the
whole cortical lineage and that their progenies resembled those
of E14 ESCs, whose cortical potential has been extensively charac-
terized previously (Gaspard et al. 2008).
Transcriptome-Wide Analysis Shows Similarities
Between In Vivo and In Vitro Cortices
Next, we performed strand-specific RNA-seq on BJ1 and JB6 cor-
tices generated either in vivo (at E13.5 and P0) or in vitro (at d12
and d21; see Supplementary Fig. 1 and Table 2). We also per-
formed RNA-seq of undifferentiated BJ1 and JB6 ESCs to mea-
sure the dynamics of gene expression during in vitro
corticogenesis and of E14-derived in vitro cortices (at d12 and
d21) as controls. At least 2 biological replicates for each recipro-
cal cross were sequenced (see Supplementary Table 2). To esti-
mate how similar to cortical tissue the cells generated in vitro
were, we performed clustering of our samples with other neural
and nonneural (liver and heart) samples retrieved from the GEO
database (see Supplementary Table 2). Biological replicates
grouped well together, demonstrating a good reproducibility
(Fig. 2A). At both time points of in vitro corticogenesis (d12
and d21), differentiated hybrid ESCs grouped with the E14-de-
rived neural cells (Fig. 2A). Our cortical samples generated either
in vivo or in vitro, clustered closer to other neural samples (cor-
tical neurons in culture and in vivo embryonic and neonatal
whole brain samples) than to nonneural samples (liver and
heart; Fig. 2A). This shows that the identity of hybrid ESC-de-
rived cells was mainly neural and that corticogenesis likely
took place as well as in the reference E14 line.
To further define the transcriptomic signature of samples,
we searched for Gene Ontology (GO) terms that were statistically
enriched among the 400most highly expressed genes whose ex-
pression was induced at least 10-fold when compared with un-
differentiated ESCs. As expected, up-regulated genes included
the established markers of DT at E13.5 (including Emx1, Otx1,
Pax6, Foxg1, Eomes, Reln, and Tbr1) and of cortex at P0 (including
Tubb3, Gria1, Shank1, Mef2c, Lmo4, and Satb2; not shown). GO-BP
(Biological Process) terms such as “neuron differentiation,”
“forebrain development,” “adhesion,” “regulation of transcrip-
tion,” and “cell motion” were enriched in vivo (see Supplemen-
tary Fig. 2). This confirms previous RNA-seq experiments on
developing cortex (Fietz et al. 2012). All these GO-BP terms, in-
cluding “forebrain development,” were also enriched in the in
vitro cortices, together with additional terms describing other
cell fates such as “vasculature” and “urogenital development”
(see Supplementary Fig. 2), whichwere observed recently in cor-
tex generated from human ESCs as well (van de Leemput et al.
2014).
To confirm that in vitro cortex identity was predominantly
neural, we plotted the normalized RNA-seq counts for known
markers of ESCs, endoderm, mesoderm, and neural fates—from
early progenitor to synaptic markers—in undifferentiated ESCs,
hybrid in vitro and in vivo cortices, and E14 in vitro cortex. Em-
bryonic liver and heart data from the GEO database (see Supple-
mentary Table 2) were also included as positive controls for
endoderm and mesoderm, respectively. As expected, the ESC
markers Pou5f1, Nanog, Lin28a, and Dnmt3l were maximal in ESC
samples (Fig. 2B). Sox2, an ESCmarker also expressed in the devel-
oping cortex (Bani-Yaghoub et al. 2006), was well expressed in in
vivo and in vitro cortices, but was absent from liver and heart
(Fig. 2B). In vivo and in vitro hybrid cortices displayed similar
overall gene expression patterns and high expression of neural
markers (Fig. 2C). However, neural markers were less expressed
in in vitro cortex and thiswas associatedwith a slight bias toward
the endoderm fate, as shown by the higher expression of Foxa2,
but there was no bias toward the mesoderm fate (Fig. 2D).
Forty-eight markers of the developing cortex, including layer
markers (Bedogni et al. 2010), were up-regulated during in vitro
corticogenesis from hybrid or E14 ESCs, in a pattern overall simi-
lar to the in vivo pattern. However, their levels of expressionwere
higher in vivo than in vitro and there were minor discrepancies
regarding the dynamic scale that was reduced in vitro for some
genes (Fig. 2E).
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Thus, specific markers and transcriptome-wide signatures
showed that hybrid ESCs generated a neural progeny resembling
the E14 ESC progeny, which was demonstrated to be fully compe-
tent to generate cortical-like cells (Gaspard et al. 2008). Therefore,
in vitro differentiation of hybrid ESCs largely reproduced the reg-
ulatory programs leading to a cortical-like fate.
Parent-of-Origin-Dependent Expression of IGs Is Highly
Concordant Between In Vivo and In Vitro Cortex
We next investigated whether the parent-of-origin-dependent
expression of IGs of in vivo cortex was conserved in vitro. Most
of the 140 known IGs investigated here contained several
Figure 1. Hybrid ESCs generate neural cells with cortical features. BJ1, JB6, and E14 ESCs (d0) were differentiated for 12 (d12) or 21 (d21) days and analyzed by
immunofluorescence and RT-qPCR. (A) The fluorescence emitted by GFP transcribed from a Pou5f1-Gfp transgene decreased during BJ1 and JB6 ESC in vitro
corticogenesis. Scale bars: 100 μm. (B) Stemness, proliferation, and corticogenesis markers were quantified by RT-qPCR in E14, BJ1, and JB6 at d0, d12, and d21. Data are
displayed as a heatmap (gray: minimal expression; dark red: maximum expression for a given gene among d0, d12, and d21) representative of at least 3 independent
experiments. (C and D) Comparison of the corticogenesis potential of hybrid and E14 ESC lines. (C) Semi-automatic quantification of the proportion of neural
progenitors, neurons, and astrocytes. The proportion of NESTIN+ cells (and TUBB3+ and GFAP+ cells, not shown) was calculated as the % of the Cy3-positive area over
the DAPI-labeled area as explained in “Material and Methods.” These positive areas are indicated as yellow dots and the obtained values (% of Nestin over DAPI) are
shown in the right panels. Scale bars: 500 μm. (D) Proportion of NESTIN- (at d0 and d12), TUBB3- (at d12 and d21), and GFAP- (at d21) positive cells in the different
cultures by the method described in (C). There were no significant differences between BJ1 or JB6 and E14 at any time point, for the 3 markers (Mann–Whitney test,
P > 0.05). (E) BJ1 and JB6 hybrid ESCs expressed the stemness marker POU5F1 at d0. At d12, hybrid NESTIN+ neuronal progenitors expressed PAX6. Neurons (TUBB3+)
and glial cells (GFAP+) were present at d21. Scale bars: 20 μm. (F) BJ1 and JB6 hybrid cells generated neurons (TUBB3+, green) that expressed markers of various cortical
identities shown in red (Cajal-Retzius cells: REELIN; preplate-layer VI: TBR1; layer Vb: CTIP2; layers II/III and Vb: BRN2). Representative pictures of 3 independent cultures
are shown. Nuclei were stained with DAPI (blue). Scale bars: 20 μm.
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Figure 2. Transcriptional identity of ESC-derived cortex is mainly neural. (A) Clustering of RNA-seq data obtained in this study (frames) and retrieved from the GEO
database: embryonic cortex (E17.5), ex vivo cortical neurons in culture, neonatal frontal cortex (P5), embryonic whole brain (E17.5 and E14.5), embryonic liver and
heart, in vitro ESC-derived heart, and E14 ESCs (see Supplementary Table 2). The red dot line separates neural and nonneural samples. (B–D) Histograms showing the
average of normalized RNA-seq counts + SEM for BJ1–JB6 hybrid ESCs at d0 (n = 4), BJ1–JB6 in vitro cortex at d12 (n = 4) and d21 (n = 4), in vitro cortex from E14 ESCs at
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SNPs and only 25, includingmanymiRNAs, had no SNP (see Sup-
plementary Table 3). After removal of the 6 known IGs on the X
chromosome, this pinpointed 109 IGs for which the parent-of-
origin-dependent expression could potentially be measured.
One hundred and seven of these were expressed in both in vivo
and in vitro cortices and amajority of these were induced during
differentiation (see Supplementary Table 4). Next, RNA-seq reads
with B6-JF1-specific SNPs were retrieved to determine the num-
ber of maternal and paternal RNA-seq reads (see Supplementary
Table 4). Data were analyzed with a novel statistical method that
we named ISoLDE for Integrative Statistics of alleLe Dependent
Expression (Reynès et al. in preparation). ISoLDE requires repli-
cates of reciprocal crosses and, in contrast to previous methods,
positively identifies both genes with parent-of-origin-dependent
expression and bi-allelically expressed genes. ISoLDE classifies
genes into 5 major categories: maternal, paternal, bi-allelic, fil-
tered out (due to insufficient numbers of reads), and undeter-
mined (UN) when ISolDE cannot affirm they are maternal,
paternal, or biallelic. In addition, UN genes showing concordant
parental biases in all replicates of both parental crosses are
flagged UN-mat or UN-pat.
ISoLDE was first applied to the in vivo samples (E13.5 DT and
P0 cortex). Of 109 IGs with at least one B6-JF1 SNP (see Supple-
mentary Table 3), 33 IGs were filtered out and 5 were UN in
both stages (Fig. 3 and see Supplementary Table 4). For the
remaining 71 IGs, 34 were bi-allelic and 37 showed a significant
parent-of-origin-dependent expression at either E13.5 or P0
(Fig. 3 and see Supplementary Table 4). This category includes
Eif2c2, A230057D06Rik, D7Ertd715e, Adam23, and Phactr2 that
were recently identified as imprinted by others (Wang et al.
2011; DeVeale et al. 2012). Twenty-eight IGs were expressed ex-
clusively from one parental allele (such as Peg10, Peg13, Cdkn1c,
H19, and Plagl1), and 9 IGs (Adam23, Blcap, Copg2, Asb4, Impact,
Eif2c2, Phactr2, Trappc9, and Ube3a) were expressed mainly from
one parental allele and also weakly from the other allele (see
Supplementary Table 4). Ube3a was the only IG whose parental
bias was significantly different between E13.5 (bi-allelic) and
the newborn cortex (preferentially maternal; Fig. 3 and see
Supplementary Table 4), as previously reported (Kohama et al.
2012).
We next compared the parent-of-origin-dependent expres-
sion of IGs between in vitro and in vivo cortices. To this aim,
we calculated a concordance score: for each comparison between
in vivo and in vitro cortices at related developmental stages (i.e.,
d12 vs. E13.5 DT and d21 vs. P0 cortex), we gave a score ranging
from 0 for a total discordance to 1 for a perfect match (Fig. 3
and see Supplementary Table 4 and Supplementary Material
for details in score calculation). The average concordance score
for the 69 IGs whose parent-of-origin-dependent expression
could bemeasured in both types of cortices was high (0.82 ± 0.28).
Notably, 41 IGs were fully concordant with a score of 1 (Fig. 3 and
see Supplementary Table 4). There was a perfect or high conser-
vation for IGs known to impact on telencephalon development
such as Mest (paternal; Sansom et al. 2005), Cdkn1c (maternal;
Mairet-Coello et al. 2012), Igf2 (UN-pat; Lehtinen et al. 2011), and
Necdin (paternal; Kuwajima et al. 2006). Only 9 IGs had a
concordance score of <0.5 (Zim1, Blcap, Gnas, Trappc9, Ei2f2c2,
Adam23, Slc38a, Slc22a3, and Zdbf2). The less concordant IGs,
with a score of 0, were Adam23 and Zdbf2, which were paternal
in vivo while they were bi-allelic in vitro (Fig. 3 and see Supple-
mentary Table 4). Igf2r and Slc22a3 were maternal in vitro and
UN-mat or bi-allelic in vivo (Fig. 3). It was previously shown
that Igf2r is bi-allelically expressed when the expression of Airn
non coding RNA is low (Sleutels et al. 2003). Indeed, we found a
lower expression of Airn in vivo when compared with in vitro
(see Supplementary Fig. 3).
Importantly, we confirmed the parent-of-origin-dependent
expression of 9 IGs determined by RNA-seq/ISoLDE using 2 alter-
native and complementary methods, RFLP and Sanger sequen-
cing of PCR products. We confirmed the bi-allelic expression of
Osbpl5 (Fig. 4A), Nap1l4, and Dhcr7 (see Supplementary Fig. 4A,B),
the paternal expression of Peg10, Peg3, and Dlk1 (Fig. 4B,E and see
Supplementary Fig. 4C), and the maternal expression of Meg3
and H19 (Fig. 4D and see Supplementary Fig. 4D), both in vivo
and in vitro. Sanger sequencing also confirmed the predominant
maternal expression of Phactr2 measured by RNA-seq at E13.5
(Fig. 4C). Thus, we conclude that the allelic expression of IGs was
highly conserved in in vitro cortex at d12 and d21 compared
with E13.5 and P0 in vivo cortices.
Faithful Maintenance of DNA Methylation at Imprinted
Loci in In Vitro Cortex
Differential DNAmethylation at imprintedDMRs,where only one
parental allele is methylated, controls the parent-of-origin-de-
pendent expression of IGs (Ferguson-Smith 2011; Kelsey and
Feil 2013). RRBS covers most CpG islands and imprinted DMRs
at base resolution, and was used to measure the dynamics of
DNA methylation in ESC-derived neural cells (Meissner et al.
2008). To assess whether the methylation at imprinted DMRs
was faithfully recapitulated in vitro, RRBS was performed on
our 13 conditions in duplicates: E14 (at d0, d12, and d21),
and BJ1 and JB6 samples (at d0, d12, d21, E13.5, and P0; see
Supplementary Table 5).
We compared all conditions using the 1 175 189 CpGs com-
mon with all of the 26 samples and that were covered by at
least 10 reads (see Supplementary Table 5 and Fig. 5). Themedian
value of CpG methylation was low in vivo (<8%) and in undiffer-
entiated ESCs (<13%), and methylation increased upon ESC dif-
ferentiation (>30%, Supplementary Table 5) in agreement with a
previous report (Meissner et al. 2008). As a control, we checked
that the methylation of the promoter and first exon of Pou5f1 in-
creased during in vitro corticogenesis (see Supplementary Fig. 6)
while Pou5f1 expression decreased (Fig. 1A,B), as reported for this
pluripotency gene (Imamura et al. 2006). Methylomes were
highly correlated between replicates (see Supplementary
Fig. 5B). The samples clustered into 3main groups: in vitro differ-
entiated cortical cells, in vivo cortex, and ESCs (see Supplemen-
tary Fig. 5A). E13.5 DT and P0 cortex samples displayed the
typical bimodal distribution of CpG methylation with CpGs
being either unmethylated or fully methylated (see Supplemen-
tary Fig. 5C). ESC profiles were intermediate with a fraction of
d12 (n = 3) and d21 (n = 3), BJ1–JB6 hybrid in vivo DT at E13.5 (n = 6) and cortex at P0 (n = 7), liver at E14.5 (n = 3), and heart at E11.5 (n = 3). Data are expressed as the % of the
maximal number of reads for each gene. (B) Differentiated cortical cells do not express ESC markers, except Sox2. (C) In vitro and in vivo cortices but not ESCs express
neural genes: Sox1, Nes, and Fabp7 (neural progenitors); Tubb3 (neurons); Dlg4, Syp, and Mtsp2 (synapse); Gfap (glia). (D) Most of the markers of nonneural fates,
endoderm (Afp and Foxa2) and mesoderm (Kdr, Pecam1, Gata4, Gata6, and Nkx2.5), are barely detected in in vitro and in vivo cortices. (E) Heatmaps representing the
number of normalized RNA-seq reads for 48 cortical markers during in vitro (from either hybrid or E14 ESCs) and in vivo corticogenesis. DT: dorsal telencephalon
(E13.5); Ctx: cortex (P0). Most of these markers are induced during both in vitro and in vivo corticogenesis.
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highly methylated CpGs shifting toward intermediate methyla-
tion. JB6 differentiated cells had the same bimodal distribution
as the in vivo samples. The methylation profiles of BJ1 differen-
tiated cells (especially at d21) were more like those of d0 ESCs
(see Supplementary Fig. 5C). Indeed, d21–BJ1 was less correlated
with other samples (see Supplementary Fig. 5B).WeusedMethyl-
Sig (Park et al. 2014) to identify Differentially Methylated CpGs
(DMCs) between hybrid ESCs and their progenies to the reference
E14 line. BJ1 and JB6 ESCswere very close to E14 ESCs as therewas
<0.08% of DMCs (with a q-value of <0.01 and a difference in
methylation >25%; see Supplementary Table 6). JB6 derivatives
were close to E14 line (<0.04% of DMCs). BJ1 samples had more
DMCs (0.4% at d12 and 10.2% at d21; see Supplementary Table 6),
confirming the differences observed in CpGmethylation distribu-
tions and pairwise correlation matrix (see Supplementary
Fig. 5B–C). These data confirmed that the methylome of hybrid
ESC-derived cortex resembled that of E14 ESC-derived cortico-
genesis. Importantly, when comparing in vitro and in vivo hybrid
cortices, therewere only 7.4%DMCs for d12 versus E13.5 and 8.7%
DMCs for d21 versus P0 cortex (see Supplementary Table 6).
Methylation was therefore not markedly affected in vitro.
Next, to determine whether methylation at imprinted DMRs
was conserved, we compared the methylation of the in vitro dif-
ferentiated cellswith their in vivo counterparts. CpGmethylation
of 26 known imprinted DMRs (see Supplementary Table 7) was
close to 50% (see Supplementary Fig. 7A–E) as expected since
one allele should be fully methylated and the other one should
be unmethylated. In contrast, 2 DMRs, Peg12- and Gpr1-DMRs,
were respectively hypo- and hypermethylated, but this was not
associated with the in vitro culture as it was observed also in
vivo (see Supplementary Fig. 7B–E). Finally, only 2 of 26 DMRs
showed a high number of DMCs between both d12 and E13.5 DT
and d21 and P0 cortex: Slc38a4-DMR was hypomethylated and
Zdbf2-DMR hypermethylated in vitro (see Supplementary Table 6
and Fig. 7B–E). H19-DMR was hypermethylated only in d21 corti-
cal cells comparedwith P0 cortex (see Supplementary Table 6 and
Fig. 7B–E) and this was confirmed by COBRA, which also con-
firmed the proper DNA methylation at Kcnq1 (KvDMR), Nnat-
DMR, and Peg3-DMR (see Supplementary Fig. 7F). Combined,
these data suggest that methylation at imprinted DMRs (without
taking into account the parental origin of the methylated allele)
was not markedly altered in vitro.
Next, we investigated whether the parental origin of methyla-
tion at imprinted DMRswas also conserved. The parental origin of
methylation of 7 loci (Mcts2,Gnas1a, Peg10,Nap1l5, Rasgrf1, Slc38a4,
and Igf2r) could not be determined because there was no B6-JF1
SNPs in the sequenced MspI fragments. Consistent with methyla-
tion data on both alleles whatever their parental origin, methyla-
tion of eachparental allelewas alsowell conserved at 14 imprinted
DMRs (Fig. 5A–C and see Supplementary Fig. 8). For instance, Im-
pact-, Plagl1-, andKcnq1-DMRsweremethylated only on themater-
nal chromosome while Dlk1-Meg3 (IG-DMR), Meg3- (or Gtl2,
promoter), and Nesp-DMRs were predominantly methylated on
the paternal chromosome in both types of cortex (Fig. 5A–B and
see Supplementary Fig. 8). This agrees with previous findings (Fer-
guson-Smith 2011). Statistical analysis revealed a significant dif-
ference in the maternal allele methylation for only 2 DMRs: H19
and Zdbf2 (Figs. 5C and see Supplementary Fig. 8 and Table 6),
which gained methylation on the maternal chromosome in in
vitro cortex (Fig. 5A and see Supplementary Fig. 8). A few CpGs
out of all the ones testedCpGs in theGrb10- andGnas-DMRs gained
paternalmethylation in vitro (Fig. 5C and see Supplementary Fig. 8
and Table 6). Parent-of-origin methylation was confirmed by tar-
geted bisulfite sequencing of 2 specific loci: Nnat (in vitro
Figure 3. The parent-of-origin-dependent expression of IGs is highly concordant
between in vivo and in vitro cortices. Statistical analysis of parent-of-origin-
dependent expression of IGs was made using ISoLDE on RNA-seq data from hybrid
BJ1 and JB6 ESCs (d0), in vitro cortex (d12 and d21), and in vivo cortex (DTat E13.5 and
Ctx at P0). IGs were called expressed from the maternal allele (pink), the paternal
allele (blue), equally from both parental alleles (i.e. bi-allelic, purple) or
undetermined (UN, white). The undetermined genes whose allelic ratios were
concordant between all the replicates of both crosses were called UN-mat (light
pink) or UN-pat (light blue). The IGs whose parent-of-origin-dependent expression
could not be determined because their informative RNA-seq read counts were too
low were filtered out (gray). Genes were sorted according to their concordance
score between in vivo and in vitro cortices which is color coded in a heatmap from
1: perfect match of parent-of-origin expression between in vivo and in vitro
cortices (black) to 0: no concordance (beige). Only the 69 IGs whose parent-of-
origin-dependent expression could bemeasured in both types of cortices are shown.







niversity of Liege user on 10 M
ay 2021
methylation similar to in vivo) and Zdbf2 (hypermethylation of the
maternal allele in vitro when compared with in vivo; Fig. 5D–F).
From the combined data,we conclude that both parent-of-ori-
gin-dependent gene expression andmethylation of in vivo cortex
are largely reproduced by in vitro cortex. Figure 6 shows examples
of discordance (Gpr1-Zbdf2 and H19-Igf2 loci) and of concordance
(Kcnq1, Peg3, and Dlk1-Dio3 loci) in the imprinting status between
in vitro and in vivo cortices.
Figure 4. Parent-of-origin-dependent expression of IGs is confirmed by Sanger sequencing and RFLPs. The parent-of-origin-dependent expression of one bi-allelically
(Osbpl5, A), 2 paternally (Peg10, B and Peg3, E), and 2 exclusively (Meg3, D) or preferentially (Phactr2, C) maternally expressed genes was confirmed. B6, JF1, and BJ1
genomic DNAs and hybrid cDNAs were PCR-amplified from in vivo E13.5 DT and in vitro d12 cortex for all genes, except Meg3 which was amplified from in vivo P0
cortex and in vitro d21 cortex. (A–C) Sanger sequencing of PCR products. For Phactr2 only (C), different ratios of B6 and JF1 gDNAs were used to ensure that Sanger
sequencing could reveal subtle differences in allelic expression. Orange arrows indicate the SNP positions. Representative chromatograms from n = 2–3 independent
experiments are shown. (D and E) RFLPs. PCR products were digested with Bsh1236i (Meg3, D) or TaqI (Peg3, E) and run into BET-stained agarose gel (2%). 100 bp ladder
(NEB) and negative PCR control (water) are shown. Representative gel pictures from 3 independent experiments are shown. Drawings illustrate the interpretation of
the data with the expressed allele colored in red (maternal) or blue (paternal) and the inactive parental allele in gray.
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Figure 5. Parental allele CpG methylation at imprinted DMRs is well reproduced by in vitro corticogenesis. (A and B) Heatmap representation of the methylation levels
obtained by RRBS for 19 imprinted DMRs on maternal (A) and paternal (B) chromosomes performed on BJ1 and JB6 at d0, d12, d21, E13.5, and P0. Values are the means
of the % of methylation in all CpGs present in each DMR in the 4 hybrid samples. (C) Sparkline representation of statistical analysis of differential methylation
between d12 versus E13.5 and d21 versus P0 cortices on maternal and paternal chromosomes measured by RRBS. Data are represented as circles whose surface
reflects the total number of CpGs tested for each of the 18 DMRs (values are indicated in Supplementary Table 6). Differentially methylated cytosines between d12
versus E13.5 and d21 versus P0 are indicated as black sectors, whereas cytosines whose methylation are conserved are colored in pink and blue for maternal and
paternal chromosomes, respectively. For example, the entirely blue and pink circles at Impact DMR show that parent-of-origin-dependent methylation was conserved
for the 9 CpGs measured at Impact DMR on both parental chromosomes, whereas the entirely black circle for d12 versus E13.5 at Zdbf2 maternal DMR indicates 15
DMCs out of 15 tested CpGs and therefore no conservation of maternal CpG methylation at Zdbf2-DMR. DMCs in Nesp DMR could not be tested because its CpGs were
covered by <10 informative reads. (D–F) Methylation pattern at 2 imprinted loci was confirmed by bisulfite sequencing. Bisulfite-treated genomic DNAs from BJ1 or JB6
in vitro (ESC d0 and d21) and in vivo (P0 Cortex) samples were PCR-amplified at the indicated loci (D, Nnat-DMR; E, Zdbf2-DMR), subcloned, and sequenced. Filled and
open circles denote methylated and unmethylated CpGs, respectively. The percentage of CpG methylation is shown in F.
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Figure 6. Summary of parent-of-origin-dependent gene expression and DNAmethylation at 5 representative imprinted loci. The average maternal expression ratio (mat/
(mat + pat)) was plotted for genes belonging to 5 imprinted loci in ESC (d0), in vitro cortex (d12 and d21), and in vivo cortex (E13.5 DT and P0 cortex) (left panels). Usp29 (d0),
Zim1 (d0), Igf2as (d0, E13.5, and P0), Ano1 (d0), Osbpl5 (d0), Phlda2 (E13.5 and P0), Slc22a18 (d0, E13.5, and P0), Kcnq1ot1 (d0), Kcnq1 (d0, d12, E13.5, and P0), Dlk1 (d0 and P0),
Begain (d0), Airn (d0, d12, E13.5, and P0), Slc22a3 (d0 and E13.5), and Gpr1 (d0, d12, E13.5, and P0) were filtered out in the samples indicated in parentheses and are thus not
represented. The right panels depict the percentage of CpGmethylated on the paternal andmaternal alleles (mean + SD of 4 hybrid samples) at the corresponding DMRs
obtained by RRBS. Note the well-conserved imprinted status in in vitro cortex at Peg3, Kcnq1, and Dlk1-Dio3 loci while methylation only, or both methylation and allelic
expression, are affected in vitro at H19-Igf2 or Gpr1-Zdbf2 loci.
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Discussion
The ability to steer the differentiation of pluripotent stem cells
toward cortical cell types in vitro is instrumental in generating
accurate alternative models of corticogenesis and in producing
cortical cells for regenerative medicine. However, this approach
is potentially limited by epigenetic variability and instability trig-
gered by cell culture, notably in ESCs (Rugg-Gunn et al. 2007;
Cahan and Daley 2013; Ma et al. 2014). Until now, the epigenetic
status of ESC-derived cortex was unknown. In the present report,
we focused on IGs because (1) several IGs are involved in brain de-
velopment and function (Wilkinson et al. 2007; Plasschaert and
Bartolomei 2015), (2) imprinted loci are exquisitely sensitive to al-
teration of their epigenetic status (Adalsteinsson and Ferguson-
Smith 2014), and (3) dysregulation of imprinting, which can
occur during in vitro culture (Greenberg and Bourc’his 2015),
is sufficient to trigger carcinogenesis (Holm et al. 2005). Parent-
of-origin-dependent transcription of IGs is the functional output
of epigenetic modifications, notably DNA methylation, at im-
printed loci (Adalsteinsson and Ferguson-Smith 2014). Therefore,
DNAmethylation and transcription can be combined to estimate
imprinting status. One technical advantage of evaluating
imprinting by RNA-seq and RRBS over ChIP-seq targeted at
histone modifications is that these 2 approaches do not rely on
antibodies that frequently show difficulties in detecting their in-
tended targets (Rothbart et al. 2015). We have studied parental
genomic imprinting on hybrid in vivo and in vitro cortices at
both epigenomic and transcriptomic levels. We conclude that
in vitro corticogenesismaintains parent-of-origin-dependent ex-
pression and DNA methylation at most imprinted loci.
The brain is a recognized hotspot for imprinting, but the
identity of IGs showing parent-of-origin-dependent expression
specifically in the cortex was unknown. We report that 34 IGs
are bi-allelically expressed and 37 IGs have a parent-of-origin-
dependent expression in the in vivo developing mouse cortex.
These numbers are consistent with previous transcriptome-
wide studies using RNA-seq on F1 hybrid embryos (Babak et al.
2008), whole brain (Wang et al. 2008; DeVeale et al. 2012), placenta
(Wang et al. 2011), and mouse embryonic fibroblasts (Tran et al.
2014; see Supplementary Table 4). We did not identify any new
IG. If new IGs were to be found, they would probably have to be
searched for in a defined cortical subtype and at a precise cortico-
genesis stage. We could not measure the allelic expression of
Gatm, Kcnk9, H13, Mcts2, and Qpct because they had no exonic
B6-JF1 SNP. Using hybrid crosses from different strains could in-
crease the repertoire of parent-of-origin-dependent gene expres-
sion, including possibly new ones. In addition, the expression of
certain IGs was fully monoallelic while other IGs were also
weakly expressed from the normally repressed allele. This partial
or “noncanonic” (Bonthuis et al. 2015) parent-of-origin-depen-
dent expression (Prickett and Oakey 2012) could be the result of
incomplete silencing or partial de-repression of the normally si-
lent allele, as observed for Dlk1 in neural stem cells (Ferron et al.
2011). Another possibility is that our samples were heteroge-
neous and composed of cells where the parent-of-origin-depen-
dent expression was absolute for a given IG, surrounded by cells
where the same IG was bi-allelically expressed. For example, Igf2
is known to be bi-allelically expressed in the choroid plexus and
meninges at P0 (Charalambous et al. 2004) and strictly paternally
expressed in other neural cell types. The heterogeneity of our in
vivo P0 cortex samples could then explain the 40%maternal–60%
paternal Igf2 expression. Isolation of pure population of cells and
single cell RNA-seq could determine whether all cells exhibit the
same parent-of-origin-dependent expression of IGs.
We quantified CpG methylation by RRBS and compared both
parent-of-origin-dependent expression and DNA methylation
at imprinted loci between in vivo and in vitro cortices. So far,
few in vitro models have reproduced the in vivo parent-of-
origin-dependent expression of IGs. The available examples in-
clude only one IG at a time: Ube3a (Kohama et al. 2012), Igf2r
(Latos et al. 2009), and Grb10 (Plasschaert and Bartolomei 2015).
Here, we faithfully reproduced the parent-of-origin-dependent
expression of 41 IGs, whether there were maternally, paternally,
or bi-allelically expressed. Notably, some IGs that were bi-allelic
in ESCs (Phactr2, Innp5f, Asb4, Mkrn3, and Ndn) switched to
the monoallelic expression observed in vivo. Our in vitro differ-
entiation system also faithfully reproduced cell type-specificme-
chanisms, as shown for Grb10. Grb10 has a unique tissue-specific
imprinting: at E14.5, expression from the paternal allele is predo-
minant in the spinal cord while Grb10 is maternally expressed in
the cortex (Garfield et al. 2011). Our data show that Grb10 expres-
sion is strictly maternal in undifferentiated ESCs and remains so
after 12 and 21 days of in vitro corticogenesis, hence mimicking
the maternal expression in E13.5 DT and P0 cortex. Our cortico-
genesis model displaying maternal Grb10 expression is comple-
mentary to that of Plasschaert and Bartolomei (2015), who
recently reproduced the paternal expression of Grb10 in the
spinal cord using ESC-derived motoneurons. Ube3a did not
switch from bi-allelic to maternal during in vitro corticogenesis,
as it did in vivo, where its maternal expression increased from
52% at E13.5 to 63% at P0 without any change in the Snrpn-DMR
methylation. Our hypothesis is that there is less Ube3a-ATS in
vitro than in vivo because there are less neurons in vitro (see neu-
ronal markers in Fig. 2C). Zdbf2 and Adam23 were the 2 most
discordant IGs: bi-allelic in vitro and strictly paternal in vivo, as
previously reported for Zdbf2 in ESC-derived neural cells and
brain, respectively (Duffie et al. 2014). These aberrant parent-of-
origin expressions were associated with, and could be due to
the aberrant hypermethylation of the maternal allele of Zdbf2-
DMR, as observed in some Beckwith-Wiedemann Syndrome pa-
tients (Maeda et al. 2014). The aberrant bi-allelic expression of
Slc38a4 in vitro was associated with a global loss of methylation
at its DMR located in the promoter of this gene. Unfortunately,
the allelic methylation status of this locus could not be deter-
mined because it has no SNP. Some changes in DNAmethylation
were not associatedwith those in allelic gene expression: theH19
maternal allele was hypermethylated in vitro, but the allelic ex-
pressions of H19 and Igf2were identical in vitro and in vivo. Reci-
procally, some changes in parent-of-origin expression could not
be linked to those inDNAmethylation. Slc22a3 and Igf2rwerema-
ternal in vitro but expressed from both parental alleles in vivo,
without any detectable change in global DNA methylation at
the Igf2r-DMR. Allelic expression at this locus is known to be
regulated by Airn, an anti-sense RNA whose expression is
required for the silencing of the paternal alleles (Sleutels et al.
2003). The higher Airn expression observed in vitro (see Supple-
mentary Fig. 3) could thus explain that the paternal alleles of
Slc22a3 and Igf2r were more repressed in vitro than in vivo.
Since we observed several differences at imprinted loci where
non coding RNAs are crucial (Ube3a-ATS at Ube3a locus, Airn at
Igf2r locus, and Liz at Zdbf2 locus), it will be important to under-
stand why these non coding RNAs could be affected in vitro. Be-
sides DNA methylation, other epigenetic features are important
for parental genomic imprinting. Recently, it was found that
somehistonemodifications correlatewith IG regulation in hybrid
ESCs and tissues (Maupetit-Mehouas et al. 2016) but the reper-
toire of these histone marks in cortex generated from ESCs is un-
known. Measuring CpG hydroxymethylation, which is prevalent
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in the brain (Kinney et al. 2011), and whose levels drop during
adaptation of mouse embryonic fibroblasts to cell culture (Nestor
et al. 2015), will also be of interest.
The observed differences between in vitro and in vivo cortico-
genesis could be linked to differences in cell composition. It is
possible that the different cortical cell typeswere correctly gener-
ated, but in proportions different from those observed in vivo.
Indeed, cortical neurons of upper layers are known to be under-
represented upon differentiation in vitro (Gaspard et al. 2008;
Hansen et al. 2011). The proportion of neurons might be in-
creased by supplementing the corticogenesis media with val-
proic acid, a histone deacetylase inhibitor that was recently
found to increase the number of upper layer neurons in in vitro
cortex (Juliandi et al. 2012). In addition, systems that allow 3D cor-
tex generation in vitro should better reflect the cytoarchitecture
and organization (and likely epigenetics) of the in vivo cortex (Eir-
aku et al. 2008; Mariani et al. 2012), although such systems have
also their limitations (Lancaster and Knoblich 2014).
Finally, as gene expression and DNA methylation were af-
fected at only a limited number of imprinted loci upon in vitro
corticogenesis, our data suggest that some epigenetic mechan-
isms were largely preserved in vitro. Certainly, imprinting is
only one component of the epigenome and other features
would need to be studied aswell. Given the reported negative im-
pact of prolonged cell culture on epigenetic marks, it would be
particularly interesting to extend our findings to human ESCs.
The period of time in culture to generate forebrain glutamatergic
neurons (Espuny-Camacho et al. 2013) and GABAergic interneur-
ons (Nicholas et al. 2013) from human ESCs is lengthened by sev-
eral months compared with mice. Furthermore, the repertoire of
genes with parent-of-origin-dependent expression in human
cortex is only partially known and may be different from the
mouse repertoire. Indeed, genes thought to be important for
human cortical development, such as FOXG1, OTX1, and P73,
are predicted to be imprinted in humans (Luedi et al. 2007),
while we found that they are bi-allelically expressed in the
mouse cortex (not shown). Epigenomic data obtained from dor-
solateral prefrontal cortex and cortical neurospheres derived
from human ESCs and recently released by the Roadmap Epige-
nomics Consortium (Roadmap Epigenomics et al. 2015) could be
mined to get insights into the epigenetic signature of in vitro
human cortex.
In conclusion, corticogenesis from mouse ESCs displays an
established repertoire of parent-of-origin expression and DNA
methylation of imprinted loci. This model could be used reliably
to unravel the molecular mechanisms involved in selecting the
expressed parental allele(s) in the context of imprinting during
cortical development. Our findings also provide encouragement
to use ESCs to model cortical development and for drug screen-
ing. The in vitro corticogenesis system could be a powerful tool
to pinpoint drugs that de-repress the silenced parental allele in
certain brain diseases associated with perturbed IG expression
(Huang et al. 2011) or to estimate the impact of ecotoxic com-
pounds on the epigenetic signatures and the development of cor-
tical cells.
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